LeftBottomBorder
Blind
Oncotech Logo
Blind
Header Image
RightBottomBorder
spacer
15501 Red Hill Avenue
Tustin, CA 92780
Phone: (800) 576-6326
Fax: (714) 566-0421

Client Services
Phone: (800) 662-6832
Fax: (714) 566-0423
 
Experts in the Field of Cancer Testing
Dedicated to Improving the Future for Cancer Patients
1/22/2008 Exiqon and Oncotech announcement 1/2008
 
12/3/2007 Oncotech and Statens Serum Institut Sign Agreement to Offer the EDR Chemotherapy Selection Assay to Hospitals in Denmark
 
11/27/2007 Exiqon to Acquire Oncotech Inc. and Enter the Market for Cancer Molecular Diagnostics in 2008
 
8/20/2007 Oncotech and TherapySelect Announce Agreement to Offer EDR Assay Therapy Selection Testing to Cancer Patients in Germany and Austria
 
7/2/2007 Oncotech Offers p27 Protein Expression Test for Colorectal Cancer
 
6/4/2007 Oncotech Announces Enhanced Breast Cancer Biomarker Testing Through Image Analysis Technology
 
2/16/2007 Oncotech Offers ERCC1 Expression Test for Lung Cancer Patients
 
2/12/2007 Favorable Medicare Coverage Decision Extended to Oncotech's Extreme Drug Resistance (EDR) Assay
 
1/23/2007 Oncotech and The Johns Hopkins University Agree to Collaborate to Advance Development of Newly Discovered Genes Associated with Aggressive Ovarian Cancer
 
9/26/2006 Oncotech Announces Collaborative Lung Cancer Study with The University of Pittsburgh Medical Center
 
9/21/2006 Oncotech Signs Exclusive License Agreement with the University of Texas for a Novel Taxane Drug Resistance Diagnostic Assay for Cancer
 
5/22/2006 ONCOTECH ANNOUNCES INTERNATIONAL EXPANSION TO ASIA
 
4/24/2006 Oncotech presents innovative gene-based cancer research involving drug response and targeted therapy at the AACR 2006 Annual Meeting
 
4/10/2006 Oncotech Announces International Expansion in Germany
 
10/17/2005 Oncotech Offers New Genomic Test for Lung Cancer
 
5/24/2004 Michael Nobel, Ph.D., Chairman of the Nobel Family Society, joins Oncotech’s board of directors
 
4/12/2004 Oncotech Presents Breast and Ovarian Cancer Research Data at the AACR Annual Meeting
 
10/21/2003 Oncotech Appoints Weidong Huang, M.D., Ph.D., as Laboratory Co-Director and Pathologist
 
10/8/2003 Bruce A. Chabner, M.D., Former NCI Division Director, Joins Oncotech's Board of Directors
 
9/10/2003 Oncotech Increases Sales Force to Support Growing Physician & Hospital Base
 
8/20/2003 Oncotech Presents 6 Promising Cancer Research Studies at the AACR Annual Meeting in Washington, D.C.
 
11/16/2001 Dennis Kibler, Ph.D. Joins Oncotech's Scientific Advisory Board As Advisor To Bioinformatics Program
 
11/9/2001 Oncotech Announces Collaborative Research with Southwest Oncology Group (SWOG)
 
11/2/2001 Oncotech and The Johns Hopkins Cancer Center Initiate Research Collaboration
 
10/15/2001 Oncotech Announces New Innovative Molecular Genetics Research Center
 

templateBottom
BottomGraphic
Blind
Home I Physician Services I Patient Services I Pharmaceutical Services I Web Mail I About Oncotech I Innovation I Contact Us
(c) Copyright 2001 - 2008 Oncotech, Inc. All rights reserved.